1st Quarter - Report

CAPITOL COUNSEL LLC for AMICUS THERAPEUTICS, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.

LobbyistCovered position, as disclosed
JOHN MARTIN —
CHARLES PATRICK MICHAELS New Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.
KAREN STONE New Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY); Senior Legislative Assistant, Rep. Steve Israel (D-NY).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Legislative and regulatory issues affecting SMID rare disease biotech companies.

LobbyistCovered position, as disclosed
JOHN MARTIN —
CHARLES PATRICK MICHAELS New —
KAREN STONE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.